Multivesicular bodies (MVBs) are endocytic compartments that contain intraluminal vesicles formed by inward budding from the limiting membrane of endosomes. In T lymphocytes, these vesicles contain pro-apoptotic Fas ligand (FasL), which may be secreted as 'lethal exosomes' upon fusion of MVBs with the plasma membrane. Diacylglycerol kinase a (DGKa) regulate the secretion of exosomes, but it is unclear how this control is mediated. T-lymphocyte activation increases the number of MVBs that contain FasL. DGKa is recruited to MVBs and to exosomes in which it has a double function. DGKa kinase activity exerts a negative role in the formation of mature MVBs, as we demonstrate by the use of an inhibitor. Downmodulation of DGKa protein resulted in inhibition of both the polarisation of MVBs towards immune synapse and exosome secretion. The subcellular location of DGKa together with its complex role in the formation and polarised traffic of MVBs support the notion that DGKa is a key regulator of the polarised secretion of exosomes. 2 FasL induces crosslinking of the Fas death receptor on the target cell and apoptosis.
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Exosomes are small-membrane vesicles of endocytic origin that are secreted by many cells. These vesicles are formed by inward budding of the limiting membrane of late endosomes, and accumulate as intraluminal vesicles (ILVs) inside multivesicular bodies (MVBs). 1 Stimulation of cells induces the fusion of the limiting membrane of the MVBs with the plasma membrane (PM) and the secretion of the ILVs, which then are termed as exosomes. 1 Cytotoxic T lymphocytes (CTLs) use both perforin/ granzyme and Fas ligand (FasL)-dependent pathways to exert their function. Regarding FasL, CTLs kill Fas þ cells by exposing pre-formed FasL on the PM at the immunological synapse. 2 FasL induces crosslinking of the Fas death receptor on the target cell and apoptosis. 3 In CTLs, FasL is located at the limiting membrane of secretory lysosomes containing perforin/granzyme with MVB structure.
2 Upon T-cell receptor activation (TCR), MVBs undergo fusion with the PM, and relocalisation of FasL to the PM occurs. 2 In addition to this transport of FasL, another mechanism for the delivery of FasL co-exists in CTLs. 4 This mechanism is because of the fact that FasL can be sorted from the limiting membrane of the MVBs to the ILVs by inward budding. 4, 5 Upon cell activation, the fusion of preexisting MVBs with the PM results in the release of exosomes containing FasL. 5 In certain cells, such as Jurkat 6 or melanoma cells 7 , this ILVs/ MVBs pathway is the main mechanism involved in FasL traffic. Accordingly, a difference exists in FasL traffic between CTLs and non-CTL cells such as Jurkat. Although in both cell types, preformed and activation-induced synthesis of FasL coexist, in Jurkat cells the majority of FasL undergoes sorting to the ILVs in MVBs and is secreted into exosomes. 5 In addition, no PM relocation of FasL was observed in Jurkat, 5 J-HM1-2.2 (see ref. 8) or melanoma cells, 7 even in the presence of metalloproteinase inhibitors to avoid shedding of FasL from the cell surface. 9 This supports that, in contrast to FasL found in CTLs, 2 in Jurkat cells none or very little FasL is located in the limiting membrane of the MVBs.
Previous results have shown the role of diacylglycerol kinase a (DGKa), a diacylglycerol (DAG)-consuming enzyme, 10 on activation 11 and activation-induced cell death (AICD) of T lymphocytes. 8 AICD was defined as an autocrine suicide triggered by TCR stimulation, which controls lymphocyte homoeostasis, 12 that can be mimicked by muscarinic type 1 receptor (HM1R) stimulation with carbachol (CCh) in J-HM1-2.2 cells. 13 AICD requires de novo synthesis of FasL 12 and its secretion into exosomes. 6, 8 Consequently, the kinetics for apoptosis initiation during AICD is slow (44-5 h) when compared with CTL-mediated cytotoxicity, which occurs in minutes. The inhibition of DGKa kinase activity increased the secretion of exosomes bearing FasL that was induced upon activation through TCR or the HM1R, a model for AICD. 8, 13 Subsequently, the enhanced secretion of exosomes led to an increase in FasL-dependent AICD. 8 These results support that the effect of DGKa on apoptosis occurs by regulating the release of exosomes bearing de novo-synthesised FasL. 8 However, from these studies it was not clear whether stimulation of T lymphocytes affects the traffic of MVBs. In addition, the regulatory point(s) on secretory traffic of exosomes controlled by DGKa remained obscure.
Secretory vesicular traffic involves several checkpoints controlled by DAG at which cellular stimulation and DGKa might function. These include the fission of vesicles at the trans-golgi network, the generation and maturation of MVBs (i.e., number of MVBs per cell and inward vesiculation within MVB), the transport of the MVBs, and their docking and fusion to the PM. [14] [15] [16] [17] To explore these possibilities, we have used pharmacological and genetic approaches.
Results
T-lymphocyte activation increases the formation of mature MVBs containing FasL. Stimulation of TCR or HM1R in J-HM1-2.2 cells induces apoptosis, 13 which occurs through the release of exosomes containing CD63 and de novo-synthesised FasL. 8 To explore the mechanisms involved in exosome secretion, we analysed the MVB markers CD63, Lamp-1 and the lipid lysobisphosphatidic acid (LBPA) in CCh-stimulated cells. Immunofluorescence analysis of CD63, FasL and LBPA showed that these markers were located in vesicles (Figure 1a) . Comparable results were obtained in cells expressing CFP-CD63 (Figure 1b) . The stimulation enhanced the number of CD63 þ , FasL þ or LBPA þ vesicles (Figure 1a ). To confirm this, a quantitative analysis was performed by flow cytometry and western blot (WB). As shown in Supplementary Figure S1 , CCh increased the fluorescence of cells stained with anti-CD63, FasL or LBPA. The subcellular fractionation on Percoll gradients (Amersham Pharmacia, Piscataway, NJ, USA) has been used to analyse FasL into secretory lysosomes from CTLs 2 and MVBs from T lymphocytes. 8 The gradient from non-stimulated cells showed that CD63 þ and Lamp-1 þ fractions 12 and 13, which had the density of MVBs (r ¼ 1.05-1.06 g/ml), 8, 18 contained some preexisting FasL (Figure 2 ). Stimulation with CCh for 6 h, which upregulates the levels of FasL mRNA 13 and protein (Supplementary Figure S1) , enhanced markedly the amount of FasL and CD63 in the fractions corresponding to MVBs 12,13 ( Figure 2 ). Thus, cellular stimulation induces the recruitment of the upregulated FasL to subcellular compartments migrating at the same density that of MVBs.
Taken together, these results might represent an increase in the formation of mature MVBs upon cell activation. Not only to analyse this but also to stress whether the molecules found in the same fractions were present in the MVBs, we carried out analysis of LBPA in cells expressing CFP-CD63. LBPA constitutes a bonafide marker for ILVs of mature MVBs. To confirm that these vesicles exhibited MVBs ultrastructure, we analysed the cells by electron microscopy. As shown in Supplementary Figure S3 , stimulation with CCh increased the number of vesicles containing an electron-dense content, with the features of MVBs observed in CTLs 19 and T lymphocytes. 5 Taken together, the data support that stimulation of cells increased the number of mature MVBs that contain FasL. We examined next the contribution of DGKa to the biogenesis of MVBs and exosomes.
Inhibition of DGKa kinase activity increases the number of mature MVBs. Fractionation on Percoll gradients has revealed the presence of DGKa in CD63 þ late endosome fractions from non-stimulated cells. 20 Similar analysis following CCh treament revealed that the increase in DGKa levels in these fractions mirrored those of CD63 and FasL, suggesting that stimulation enhances the formation of DGKa-enriched MVBs (Figure 2 ). We have shown that inhibition of DGKa kinase activity increased exosome release. 8 As CCh enhances association of DGKa with subcellular fractions containing MVBs, we analysed the influence of DGKa kinase activity on the formation of MVBs upon stimulation. Treatment of the cells with the inhibitor of type I DGKs R59949 (see ref. 21 ) enhanced the number of exosomes secreted in non-stimulating conditions as determined by FACS; this effect was stronger in response to CCh (from 6481 up to 9410 events) (Figure 3a) . DGKa inhibition resulted in higher levels of CD63 and its redistribution in fractions containing MVBs (Figure 3b) , and enhanced the ability of CCh to increase the number of vesicles decorated with CD63 and the number of LBPA Figure S3) , and contained both CFP-CD63 and LBPA (not shown). Together, these data indicate that the inhibition of DGKa kinase activity enhances the formation of CD63 þ , LBPA þ mature MVBs, which correlates with the enhanced release of exosomes.
Inactive DGKa colocalises with MVBs. Previous experiments demonstrate that DGKa is found in subcellular fractions containing MVBs, and suggest a negative function of DGKa kinase activity in the formation of mature MVBs. If this is the case, then DGKa might be found associated with the limiting membrane of MVBs, sorted to the ILVs and then secreted in exosomes. We have demonstrated that DGKa localisation is negatively regulated by its own kinase activity, as R59949 enhances association of DGKa to membranes. 11 Therefore, we used confocal microscopy to investigate the effect of the inhibition of DGKa kinase activity on DGKa localisation. CCh in the presence of R59949 induced, in addition to the described translocation of GFP-DGKa to the 2 cells were stimulated with CCh for 6 h and then were imaged by confocal microscopy using antibodies specific for CD63, FasL and LBPA. Lamp-1 is mostly present on the limiting membrane of MVBs, whereas CD63, and particularly LBPA, are abundant in the ILVs, 27 and therefore label mature MVBs. LBPA is a phospholipid that participates in the maturation of MVBs 33 and constitutes a bonafide marker for ILVs of mature MVBs. 33 The z- Figure S4) , we analysed by WB, the exosomes secreted from cells stimulated with CCh, in the presence or the absence of R59949, for the presence of DGKa. As shown in Figure 4c , the amount of DGKa secreted in the exosomes mirrored the increase corresponding to other proteins (i.e., CD63) or inducible FasL (compare CCh 500 with CCh 500 plus R59949).
Traffic of MVBs.
To analyse the contribution to exosome secretion of the transport and fusion of MVBs to the PM, and to assess the effect of DGKa on these events, we analysed the traffic of MVBs. To this end, we used expression vectors for the MVB/exosome marker CD63 fused to GFP, DsRed2 or CFP. As shown in Figure 5a , CCh enhanced the amount of GFP-CD63 þ and DsRed2-CD63 þ exosomes secreted by transfected cells, as seen with endogenous CD63 (Figure 4c Overexpression of DGKa inhibits the formation of mature MVBs. If the effect of R59949 is exerted through the inhibition of DGKa kinase activity, it would be expected that overexpression of the enzyme would decrease the number of mature MVBs, leading to a reduction in exosome secretion. 8, 20 To study the number of mature MVBs, we analysed the distribution of CD63 and LBPA in cells co-transfected with CFP-CD63 and GFP-DGKa, GFPVPS4wt and GFP-VPS4EQ. The expression of a VPS4 ATPase-defective mutant, VPS4EQ, constitutes a control for aberrant MVBs maturation. 22, 23 As shown in Figure 6 , GFP-VPS4wt was cytosolic, whereas VPS4EQ accumulated in a few, bright-fluorescent foci that co-localised with CFP-CD63 and LBPA ( Figure 6 and Supplementary Figure S5 With regard to the effect of DGKa on the traffic of CD63-containing vesicles, the analysis of CD63 relocation at the PM, induced by CCh stimulation, showed no differences between GFP-DGKa þ and GFP-DGKa À cells (Figure 6b , top panels) at several time points; the same result was observed in VPS4EQ þ cells (Figure 6b , lower panels). Thus, the expression of DGKa or VPS4EQ seemed not to affect the transport, docking and fusion of the CD63 þ vesicles to the PM in a non-polarised model of secretion.
The recognition of target cells by CTLs induces polarisation of MVBs towards the immune synapse, and the polarised transport, docking and fusion of MVBs with the PM at the synapse. 2 Therefore, the accumulation of CD63 at the PM in a synapse model provided information to extend the findings regarding the role of DGKa on secretion to a polarised situation. To perform these experiments, we used Raji cells presenting Staphylococcal Enterotoxin E (SEE) to Jurkat cells 24 expressing GFP-CD63. As seen in Supplementary Figure S6 , recorded 5 h after synapse formation, there was an accumulation of GFP-CD63 þ vesicles close to the synapse; the movement of vesicles in and out from this area was recorded (Supplementary Videos 5 and 6, Supplementary Figure S6 ). In addition, an accumulation of GFP-CD63 in the cell surface was observed. We verified that overexpression of DGKa was inhibited, and the inhibition of DGKa increased the secretion of exosomes in the synapse (Figure 7 ), as seen in the non-polarised model (compare Figure 7 with Figures 4c  and 5a ). Subsequently, we tested that R59949 specifically reverted the inhibition on exosome secretion exerted by DGKa but not by DGKz, as the inhibitor partially rescued the inhibitory effect of DGKa on exosome secretion, but not the effect corresponding to DGKz (Figure 7 ).
The absence of DGKa inhibits the polarised traffic of MVBs. As it is possible that the absence of DGKa may exert a different effect on secretion when compared with the inhibition of the kinase activity of DGKa, we analysed polarised traffic and secretion in cells lacking DGKa. As seen in Figure 8a , pSuper-siRNA humanDGKa plasmid reduced the amount of DGKa protein when compared with non-relevant plasmids (Figure 8a ). This seemingly low reduction was more pronounced when DGKa was analysed in selected GFP þ cells (Figure 9b ). The interference on DGKa inhibited the polarised secretion of GFP-CD63 þ exosomes induced by SEE (Figures 8b and c) . We aimed to reveal traffic events underlying the effect of DGKa In the upper row, the dot plots correspond to the events recorded -the number of events is included inside each plot -in the cell culture supernatants from cells treated as indicated, whereas the lower row plots register the events from complete medium treated with different reagents but in the absence of cells. The lower row dot plots registered a constant number of events; thus events above this background should be considered as specific, cell-produced vesicles. In the right-hand side, dot plots corresponding to 50 and 100 nm latex beads, analysed in parallel, are included as a reference. Diacylglycerol kinase a regulates exosome secretion R Alonso et al interference on secretion. Thus, we analysed the relocation of endogenous CD63 to the synapse, which is consequence of the degranulation of MVBs. 2 As seen in Figure 9a 
Discussion
Our data support that T-lymphocyte activation increases the number of mature MVBs that contain FasL on their ILVs. Besides this effect of cell activation on formation of mature MVBs, an increase in mobilisation, docking and fusion of these MVBs to the PM might underlie the stimulated release of FasL-bearing exosomes. The inhibition of DGKa kinase activity, previously shown to enhance exosome secretion, 8 also increases the formation of mature MVBs induced upon activation. However, we could not rule out a nonspecific effect of the inhibitor. Thus, we tested that the inhibitor acted on DGKa, but not on DGKz, as the inhibitor did not rescue DGKz-induced inhibition of exosome secretion (Figure 7) . To examine a possible negative function of DGKa kinase activity in the transport, docking and fusion of MVBs with the PM, we overexpressed DGKa and analysed these events. We observed that DGKa negatively regulated the formation of mature MVBs, but did not appear to affect their subsequent traffic. In contrast, the association of DGKa with MVBs, the effect of DGKa on the formation of mature MVBs, the association of DGKa with exosomes and its role on exosome secretion, are compatible with the idea that DGKa kinase activity is an important negative regulator of the formation of MVBs. The fact that inhibition of DGKa kinase enhances the number of mature MVBs and partially rescues the inhibition of exosome secretion, conferred by DGKa overexpression, supports the notion of DGKa kinase activity function as an important negative regulator of polarised and non-polarised exosome release. In addition to the positive effect of the inhibitor on the inducible secretion, we observed also a positive effect on the constitutive secretion of exosomes (Figures 3a and 5a) . 8 It is known that there is constitutive DAG production at intracellular membranes. 25 This DAG pool is necessary for constitutive vesicular traffic, 15 and R59949 has been shown to enhance basal DAG levels on , 25 probably by inhibition of DGKs. Thus, it is conceivable that the inhibitor -by affecting intracellular DAG pools-might positively control the constitutive traffic of MVBs, and subsequently, the basal secretion of exosomes.
We investigated the role of DGKa in the polarised secretion of exosomes. By using an interference approach on a synapse model, we uncovered a positive role of DGKa on exosome secretion. In DGKa-interfered cells, polarisation of MVBs and subsequent exosome release were reduced ( Figure 9 ). This, together with the fact that the kinase inhibitor increases polarised secretion of exosomes ( Figure 7) implies that some non-kinase function of DGKa is required for polarised secretion. The fact that R59949 partially rescues the negative effect of DGKa overexpression on exosome secretion (Figure 7) , along with the inhibitory effect that DGKa downmodulation produces on MVBs polarisation and degranulation (Figures 8 and 9 ), suggest that different functional domains of DGKa negatively and positively control the secretory traffic of exosomes at, at least, two distinct regulatory points. Whereas the kinase domain appears to be negatively involved in formation of mature MVBs, other(s) domain(s) would be positively involved in MVBs polarisation. Although both the nature of these domains and their effectors remain unknown, our results point out to a complex, fine-tuned control of the secretory traffic of exosomes exerted by DGKa.
The lipid composition of vesicles constitutes a factor in the maturation of MVBs that is susceptible to regulation by DGKa. The contribution of LBPA is of interest, as LBPA provides negative curvature to the MVB-limiting membrane during the inward invagination to form the ILVs. 26 In the latter study, it has been shown that ALIX, a protein that interacts with ESCRT complexes, binds to LBPA-containing liposomes. When ALIX levels were downregulated, the formation of LBPA-containing endosomes decreased. 26 Thus, ALIX Figure 6 Expression of GFP-DGKa affects the formation of mature MVBs and the distribution of LBPA þ vesicles, but does not inhibit the accumulation of CD63 at the plasma membrane. Jurkat cells expressing GFP-VPSwt, GFP-VPS4EQ mutant or GFP-DGKa, together with CFP-CD63, were stimulated with CCh to induce the formation and traffic of MVBs, and LBPA was stained as indicated in Materials and Methods. The endosomal sorting complex required for transport (ESCRT) machinery is involved in the formation of the intraluminal vesicles of MVBs, and the AAA-ATPase vacuolar protein-sorting VPS4 regulates the recycling of the ESCRT complexes. 34 The expression of a VPS4 ATPase-defective mutant, VPS4EQ, inhibits the inward budding at the limiting membrane of MVBs and the subsequent formation of ILVs. 22, 35 These effects result in the formation of immature, large endosomes, 22, 23 and thus the expression of VPS4EQ mutant constitutes an appropriate control for aberrant MVBs maturation. regulates the maturation of MVBs. LBPA is locally produced in MVBs, 26 but the steps involved in LBPA synthesis remain unclear. Therefore, it will be interesting to analyse the consequences of the regulation of DAG levels by DGKa on both the synthesis of LBPA and the recruitment of ALIX/ ESCRT to the MVBs. One possibility that might explain the inhibition of exosome secretion by DGKa, and the fact that DGKa overexpression inhibits the formation of LBPA þ vesicles is that the enzyme would affect the maturation (number of ILVs) of MVBs. If this is the case, then DGKa could be found associated with the MVBs and secreted in exosomes, as we have shown. Thus, quite probably, DGKa controls the inward budding in MVBs. The changes induced by R59949 in the distribution of CD63 on gradients (Figure 3b ) support this hypothesis, as the maturation of late endosomes/ MVBs is associated with an increase in their content in LBPA, which confers a shift in the density of MVBs. 27 Apart from this potential role of DGKa on the lipid composition of MVBs, it is conceivable that DGKa activity might affect the gradient of DAG at the synapse; this gradient is crucial for MTOC polarisation in CTLs. 17 DGKa relocates to the PM upon cell activation and regulates the intensity of signalling of DAG-controlled pathways in T lymphocytes, 11 thus it is conceivable that DGKa may contribute to maintain a DAG gradient at the synapse. Loss of this gradient, as a result of DGKa downregulation, could be responsible for the defect in MVBs polarisation and degranulation. However, our data showing that R59949 increases polarised secretion of exosomes rules out that the inhibition of polarised secretion in DGKa-interfered cells might be because of the absence of DGKa kinase activity that would otherwise control a DAG gradient at the PM. Our results describing an increment in exosome secretion by treatment with R59949 are in apparent contradiction with the studies by Quann et al., 17 showing that DGK kinase activity is required to maintain a stable DAG gradient. Treatment of CTLs with R59949 induced a defect in the persistence of both MTOC polarisation and the secretion of cytolytic factors towards the synapse and CTL-mediated killing. 17 The divergence may be because of the fact that mouse CTLs, instead of human cell lines, were used in that study; 17 and no evaluation of the secretion of exosomes and their contribution to apoptosis was performed. In addition, in DGKa-overexpressing cells, the secretion of exosomes is reduced, and there are few CD63 þ LBPA þ vesicles per cell. However, the MVBs are transported, docked and fused normally with the PM in cells overexpressing DGKa. Thus, the inhibition of the formation of mature MVBs appears to be the limiting step in secretory traffic of exosomes, at least in cells overexpressing DGKa. As GFP-DGKa translocates to the PM, it is conceivable that the gradient of DAG at the synapse, which may control MVBs polarization, 17 is maintained in these cells. In contrast, in DGKa-interfered cells, the defective polarisation of MVBs would constitute a different limiting step for exosome secretion. Experiments involving the use of 'caged' dioctanoylglycerol, 17 photoactivable at different locations (synapse, MVBs), and the expression of DAG sensors, such as C1 domains of PKCy fused to GFP, 25, 28 might help to evaluate spatio-temporal changes of DAG levels, both in DGKa-overexpressing and in DGKa-interfered cells, and to study the consequences of these changes on traffic of MVBs and exosome secretion.
Taken together, our data support the idea that the combination of positive signals triggered by receptor stimulation and a fine-tuning effect of a negative regulator, that is, the kinase activity of DGKa control the secretory vesicle pathway that is responsible for the secretion of exosomes. The negative effect of DGKa kinase activity on traffic was exerted at the stage of formation of mature MVBs. In addition, a nonkinase function of DGKa is necessary for polarisation of MVBs and exosome secretion. These inferences might conciliate the DGKa interference data, with the fact that R59949 kinase p E F -G F P -
p<0.0001 NS inhibitor enhances polarised secretion and rescues the negative effect of DGKa overexpression on exosome secretion. Thus, DGKa appears to coordinate both positive and negative signals that are exerted at two different stages of the traffic of MVBs; the balance of these signals seems to be crucial for exosome secretion.
Materials and Methods
Cell cultures. J-HM1-2.2 cells expressing HM1R have been described; 29 these cells stimulated with agonist CCh have been widely used as an appropriate model to induce full activation signals 11 and AICD. 13 Raji B cell line was from ATCC (Teddington, UK).
Antibodies and reagents. The anti-DGKa antibody (Ab) for WB and immunofluorescence was from Abnova (Taipei City, Taiwan). Anti-FasL (CD95L) NOK-1 mAb, anti-Lamp-1 (clone 25), anti-CD3 (UCHT1) and anti-FasL G247-4 for immunofluorescence were obtained from BD Biosciences (San Jose, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal anti-FasL (CD95L) Q-20 for WB was from Santa Cruz Biotechnology. Anti-CD63 (clone NKJ-C-3) was from Oncogene (Darmstadt, Germany). Anti-Golgi 58K protein (clone 58K-9) was from Sigma (Lyon, France). Anti-LBPA Ab 6C4 was a kind gift from Dr. J Gruenberg. All horseradish peroxidase-coupled secondary antibodies were from Dako (Glostrup, Denmark). Carbachol was from Sigma. The DGK inhibitor II (R59949) was purchased from Calbiochem (Darmstadt, Germany). This inhibitor is specific for the type-I DGK isotypes (as DGKa) but does not inhibit DGKz (see ref.
10,21) (the other DGK isotype expressed in T lymphocytes 30 ). Alexa Fluor-coupled secondary antibodies were from Invitrogen (Carlsbad, CA, USA). Staphylococcal Enterotoxin E was from Toxin Technology, Inc. (Sarasota, FL, USA). Cell tracker blue (CMAC) was from Invitrogen.
Expression vectors, siRNA interference vectors and transfection assays. The plasmids pEFbos-GFP, pEFGFP-DGKa, pEFGFP-DGKz have been described. 8, 11, 30 pEFGFP-C1bosCD63 and pECFP-C1CD63 were a generous gift from Dr. G Griffiths. pDsRed2-CD63 was prepared by subcloning cDNA corresponding to human CD63 from pEFGFP-C1bosCD63 into pDsRed2-C1 vector (BD Biosciences). Expression vectors for GFP-VPS4wt and GFP-VPS4EQ mutant were a gift from Dr. P Whitley.
31 siRNAs expression was achieved by using pSUPER RNAi System (pSR-GFP bicistronic or pSuper plasmids) (Oligoengine, Seattle, WA, USA). One sequence of human DGKa isoform was selected to generate 64 bp double-strand DNA oligonucleotides encompassing the 19-nucleotide interfering sequence 5 0 -GCCAGAAGACCATGGATGA-3 0 and a hairpin-forming sequence, which were cloned in these plasmids. Equivalent sequences 5
0 -ACACAAGACCACAGATGAT-3 0 (mouse DGKa) or 5 0 -CTATGT GACTGAGATCGCA-3 0 (human DGKz) for DGK isoforms were used in negativecontrol plasmids. For transfection experiments, cells were transiently transfected with 20-30 mg of the plasmids as described. 32 Expression vectors for DGKs or siRNAs vectors were co-transfected in Jurkat cells in molar excess (3 : 1) to exosome reporters (GFP-CD63).
Isolation of exosomes. The exosomes produced by equal number of cells for each experimental condition were isolated from the cell-culture supernatants as previously described. 6, 7 Using these standard protocols, culture supernatants of 20 Â 10 6 cells were centrifuged at low speed in sequential steps, and then clarified to eliminate cells and cell debris. To obtain the exosomes from cells expressing the exosome reporters GFP-CD81, GFP-CD63 and DsRed2-CD63, a similar protocol was performed, although 1 Â 10 6 effector cells (Jurkat) were used. For the secretion of exosomes in immune synapse experiments, expression vectors for DGKs or siRNAs vectors were co-transfected in Jurkat cells in molar excess (3 : 1) to exosome reporter vectors (i.e., GFP-CD63), and the formation of synapses with Raji cells in the absence (control) or presence of superantigen (SEE) was performed at 2-3 days after transfection, as described below. The exosomes were recovered by ultracentrifugation (100 000 Â g for 12 h) as described, 6 and resuspended in 50 ml of RIPA lysis buffer, or directly quantified by flow cytometry (see below). We usually loaded 25 ml of this lysate per lane for WB analysis. We commonly obtained between 50-150 mg of protein in the 100 000 Â g pellet from 20 Â 10 6 CCh-stimulated cells. In the experiments that involved the isolation of exosomes and WB, each lane of the blot contained the total protein that was recovered in the culture medium from the same number of cells, untreated or treated with stimuli in the presence or in the absence of DGK inhibitor. The lysates of the cells recovered after the first step of the protocol for exosome isolation were run in parallel to the exosomes, to internally normalise WBs by viable cell number at the end of the culture period for exosome secretion, but also to normalise transfection efficiency of the XFP-CD63 reporter. Alternatively, the number of exosomes in the clarified culture supernatants was quantified by flow cytometry, using a constant acquisition period (5 min) and calibration fluorescent beads (50 and 100 nm beads, from Sigma). Forward-and side-scatter light detectors, together with gating regions, were set up to detect properly the calibration beads, and the absolute number of gated events equal to the number of exosomes was represented using dot plot (forward versus side-scatter) analysis. In parallel, samples corresponding to complete medium including the different reagents, but in the absence of cells, were analysed, and these dot plots registered a constant number of events; thus events above this background were considered as specific, cell-produced vesicles. Western blot analysis. Cells and exosomes were lysed for 10 min in RIPA buffer containing protease inhibitors, and the proteins were separated by SDS-PAGE under reducing conditions and transferred to Hybond ECL membranes (GE Healthcare, Piscataway, NJ, USA). For CD63 detection, proteins were separated under non-reducing conditions as described. 8 After incubation with the appropriate primary antibody, the blots were developed with horseradish peroxidase-conjugated secondary antibodies using enhanced chemiluminescence reagents and following standard protocols.
Cell fractionation. J-HM1-2.2 cells were disrupted in 2 ml of an iso-osmotic homogenisation buffer 2 and the homogenate was fractionated on a discontinuous Percoll (Amersham Pharmacia) gradient as described. 2, 8 The subcellular fractions, from the same number of control and stimulated cells, were analysed in parallel for the presence of CD63, FasL, DGKa and Lamp-1 proteins by WB. Lamp-1 was used as an appropriate, internal loading control. Density was calibrated using density marker beads (Amersham Pharmacia).
Electron microscopy. JHM1-2.2 cells were fixed for 20 min at RT in 2% PFA/ 1.5% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4. Cells were washed twice in 0.1 M sodium cacodylate and were spun into a tight pellet for osmication with 1.5% potassium ferricyanide, 1% osmium for 1 h at 4 1C. The cell pellet was washed several times with 0.1 M sodium cacodylate and incubated with 1% tannic acid in 0.05 M sodium cacodylate for 45 min at room temperature. The cell pellet was rinsed in 1% sodium sulphate in 0.05 M sodium cacodylate for 5 min and with dH 2 O for 3 min. The cell pellet was dehydrated stepwise in ethanol (70-90% absolute ethanol). Ethanol was removed and propylene oxide was added for 2 Â 10 min, and the cell pellet was embedded in 1 : 1 mixture of epon and propylene oxide. Ultrathin sections (60-70 nm) were cut on an ultramicrotome, collected onto grids and examined with a Philips EM420 transmission electron microscope (Hillsboro, OR, USA).
Immunofluorescence analysis. For fluorescence analysis of living J-HM1-2.2 cells expressing the different constructions, cells were attached to glass bottom 35 mm culture dishes (Mat-Tek, Ashland, MA, USA) using fibronectin at 24-48 h post transfection, and stimulated in culture medium without phenol red at 37 1C. 32 In some experiments, immune synapses between GFP-CD63-expressing Jurkat cells and Raji B cells, pulsed with superantigen SEE and labelled with CMAC, were performed as previously described. 24 Subsequently, epifluorescence images were taken with a Nikon Eclipse (Melville, NY, USA) TE2000S microscope equipped with a DS-5M digital camera and a Plan Apo VC Â 60 NA 1.4 objective. Time-lapse analysis was performed in living cells using ACT2-U software or NIS-AR software (NIKON). After the culture period, samples were either cell-surface stained or fixed and stained as described 32 with primary Abs (anti-CD63, anti-LBPA, anti-DGKa and anti-FasL) and appropriate secondary Alexa Fluor-conjugated abs (Invitrogen). Confocal microscopy was performed using a Bio-Rad (Hercules, CA, USA) Radiance 2100 scan head mounted on a Nikon ECLIPSE TE 2000U microscope and using Â 60 NA 1.4 PlanApo objective. No labelling was observed when using the secondary abs alone. The z axis projection (maximum intensity) and merged images for colocalisation experiments were performed using ImageJ software (Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, MD, USA, http:// rsb.info.nih.gov/ij/, 1997-2004). For quantification, digital images were analysed using EasiVision SIS image analysis software (Soft Imaging Software, Munster, Germany) and ImageJ software. Experimental significance of the results obtained at the single-cell level was achieved by analysing a minimal number of 60 cells (unless otherwise indicated) from different microscope fields, and a minimal number of three independent experiments. Results were expressed as average minus/plus standard deviation (S.D.), and correspond to the means of the separate experiments, and not to the pooled cells measured together. ANOVA analysis was performed for statistical significance of all the results. Trajectories of vesicles in videos were plotted by using NIS-AR software (NIKON). Epifluorescence image improvement was achieved by using deconvolution software (Huygens, Hilversum, The Netherlands, SVI). 
